fbpx
November 25, 2022

Managing T-DXd Adverse Events in the Real World Managing T-DXd Adverse Events in the Real World

With recent expansions in its breast cancer indications, there has been an increase in the use of trastuzumab deruxtecan (T-DXd; Enhertu). “A lot of us are […]
November 25, 2022

FDA Rejects Piziotinib for Certain Types of NSCLC FDA Rejects Piziotinib for Certain Types of NSCLC

The US Food and Drug Administration (FDA) has announced that it will not approve poziotinib (Spectrum Pharmaceuticals) for the treatment of certain patients with nonsmall-cell lung […]
November 23, 2022

FDA Requests More Restrictions on Ovarian Cancer Drugs FDA Requests More Restrictions on Ovarian Cancer Drugs

The US Food and Drug Administration (FDA) is moving to further restrict the use of certain PARP inhibitors in patients with ovarian cancer, citing recent data […]
November 23, 2022

FDA Approves First Gene Therapy for Hemophilia B FDA Approves First Gene Therapy for Hemophilia B

The U.S. Food and Drug Administration has approved etranacogene dezaparvovec (EtranaDez), the first gene therapy option for adults with hemophilia B who currently use factor IX prophylaxis therapy, […]
November 22, 2022

Over Half of Targetable NSCLC Patients Miss Out on Correct Tx Over Half of Targetable NSCLC Patients Miss Out on Correct Tx

Nearly two thirds of patients with advanced non–small cell lung cancer (NSCLC) who are eligible for targeted therapy are not receiving these drugs because of gaps […]
November 21, 2022

Data Hint COVID-19 Vax May Improve Immunotherapy Efficacy in Some Data Hint COVID-19 Vax May Improve Immunotherapy Efficacy in Some

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. While studies have generally alleviated concerns that COVID-19 vaccination could compromise the […]
November 18, 2022

Optimal Radiation Regimen When Breast Cancer Recurs? Optimal Radiation Regimen When Breast Cancer Recurs?

The study covered in this summary was published on Research Square as a preprint and has not yet been peer reviewed. Key Takeaway Among patients with […]
November 18, 2022

Atezolizumab Fails to Improve Outcomes in Postsurgery Kidney Cancer Atezolizumab Fails to Improve Outcomes in Postsurgery Kidney Cancer

Adjuvant immunotherapy with atezolizumab for patients with renal cell carcinoma who have had a nephrectomy with or without a metastasectomy, failed to improve clinical outcomes in […]
November 18, 2022

Chronic Stress, Especially Race Related, May Hasten Cancer Death Chronic Stress, Especially Race Related, May Hasten Cancer Death

The American folk hero John Henry pitted his hammer against a mechanical steam drill, only to die of exhaustion after winning the battle. In the legend, […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0